研究生学术报告预告登记(开题、中期、答辩)

       为加强研究生学术交流活动,推进学术创新,特开通“研究生学术报告预告区”。我校研究生和教师可以在预告区及时发布和了解有关研究生学术报告的信息,届时参加。也可就某学术报告展开专题讨论与交流。

报告人: 夏婷
学号: 2016213033
学院: 药物科学与技术学院
报告类型: 第一次学术报告
日期: 18 November 2017
时间:
地点: 24教学楼406
导师: 王娟
题目: 胃肠安丸全方对伊立替康引起的肠道损伤的保护作用
内容提要:

Wei Chang An pills (WCA pills), a traditional Chinese
patent drug, have been widely used in clinical for many gastrointestinal
diseases, such as irritable bowel syndrome and functional diarrhea. The aim of
study was to demonstrate the protective effect of WCA on irinotecan (CPT-11)
induced intestinal damage in mice.In order to
illustrate the potential mechanism of WCA on mucositis, the effect of Houpo
(HP), the main herb in WCA, its major components magnolol (MG) and honokiol
(Hon) were conducted to demonstrate its efficacy. Irinotecan hydrochloride, as
known as CPT-11, is an effective and common drug for colon cancer patients. But
the intestinal toxicity limits its antitumor effect. Therefore, WCA was applied
to evaluate its efficacy on intestinal protective effect in CPT-11 treated CT26
tumor bearing mince. Co-treatment of WCA modulated the body weight loss, decreased
the severity of intestinal mucositis by improving histopathological parameters,
suppressing oxidative stress, regulating the inflammatory response to exhibit
its function in alleviating gastrointestinal toxicity induced by CPT-11, but
would not change the anti-tumor effect of CPT-11.

图片:
登记人: 夏婷
登记时间: Tuesday, 16 April 2019, 8:47 AM